Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.17 (
ornithine decarboxylase
)
6,351
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study was designed to determine whether
transforming growth factor alpha
(TGF alpha) protects rat gastric mucosa against ethanol- and aspirin-induced injury. Systemic administration of TGF alpha dose-dependently decreased 100% ethanol-induced gastric mucosal injury; a dose of 50 micrograms/kg delivered intraperitoneally 15 min before ethanol decreased macroscopic mucosal injury by > 90%. At the microscopic level, TGF alpha prevented deep gastric necrotic lesions and reduced disruption of surface epithelium. Pretreatment with orogastric TGF alpha (200 micrograms/kg) only partially (40%) decreased macroscopic ethanol damage. Intraperitoneal administration of TGF alpha at a dose of 10 micrograms/kg, which does not significantly inhibit gastric acid secretion, decreased aspirin-induced macroscopic damage by > 80%. TGF alpha protection does not seem to be mediated by prostaglandin, glutathione, or
ornithine decarboxylase
-related events, as evidenced by lack of influence of the inhibition of their production. Pretreatment with the sulfhydryl blocking agent N-ethylmaleimide partially abolished (40%) the protective effect of TGF alpha. In addition, systemic administration of TGF alpha resulted in a two-fold increase in tyrosine phosphorylation of phospholipase C-gamma 1 and in a time- and dose-dependent increase in levels of immunoreactive insoluble gastric mucin; these events occurred in a time frame consistent with their participation in the protective effect of TGF alpha.
...
PMID:Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. 128 34
These experiments were designed to test polyamine (PA) involvement in the secretion and action of
transforming growth factor alpha
(
TGF-alpha
) in hormone responsive MCF-7 breast cancer cells in liquid culture. At the same time, we evaluated the influence of culture conditions (with serum vs. serum depleted) and subclonality of MCF-7 cells on PA involvement in estrogen (E2) and
TGF-alpha
stimulated cell proliferation. Despite inducing a profound suppression of cellular PA levels and inhibiting basal and E2-stimulated growth, administration of the PA synthesis inhibitor alpha-difluoromethylornithine (DFMO) did not influence either basal or E2-induced
TGF-alpha
secretion. In the same experiments, on the other hand, addition of DFMO completely blocked the growth stimulatory effect of exogenous
TGF-alpha
. However, when the culture conditions were changed to serum-free medium,
TGF-alpha
and E2-induced cell proliferation was affected modestly or not at all by DFMO administration, despite similar suppression of cellular
ornithine decarboxylase
(
ODC
) activity and PA levels. In addition, different clones of MCF-7 cells differed in their sensitivity to the antiproliferative effect of DFMO as well as in basal levels of
ODC
activity and PA. We conclude that PAs are not involved in basal or E2-stimulated
TGF-alpha
secretion in MCF-7 breast cancer cells. On the other hand, PAs do seem to be important mediators of
TGF-alpha
and E2-induced breast cancer cell proliferation, though the degree of such involvement appears to be influenced by serum factors and clonal variability of MCF-7 cells.
...
PMID:Polyamine involvement in the secretion and action of TGF-alpha in hormone sensitive human breast cancer cells in culture. 191 11
In situ methodologies allow qualitative and semi-quantitative analysis of spatial gene expression in whole organisms or tissues. We have applied quantitative autoradiography to in situ hybridizations of sections from human breast tumor xenografts to measure mRNA levels for
ornithine decarboxylase
, estrogen receptor,
transforming growth factor alpha
, and glyceraldehyde-3-phosphate dehydrogenase. Comparisons of control and tamoxifen-treated animals show significant decreases in MCF-7 tumor estrogen receptor mRNA levels in the drug-treated animals. Combining quantitative autoradiography with in situ hybridization allows measurement of absolute rather than relative mRNA levels for genes of interest, and to monitor effector-induced changes in these mRNAs in vivo.
...
PMID:Measurement of mRNA levels in tumor xenografts with quantitative autoradiography and in situ hybridization. 778 31
Rapid repair by cell migration, a process called "restitution", is essential for wound healing of mucous epithelia. Here, an established in vitro model for restitution, i.e., migration of the non-transformed intestinal epithelial cell line IEC-18 after scratch wounding, was investigated. This cell line is also known for its retained differentiation potential. The aim of this study was to test by expression profiling whether the differentiation state is altered during restitution in vitro. Using a sensitive RT-PCR method a systematic analysis of separated stationary and migratory cells was performed 48 h after in vitro wounding. Most characteristically, the differentiation state was changed in migratory cells when compared with stationary cells. For example, migratory cells lost markers of terminal differentiation and changed to a phenotype that assists the process of restitution by up-regulating the expression of genes such as plasminogen activator inhibitor-1,
transforming growth factor alpha
, heparin-binding EGF-like growth factor, alpha-smooth muscle actin,
ornithine decarboxylase
, and glyceraldehyde-3-phosphate dehydrogenase. However, there were no unequivocal signs of epithelial-mesenchymal transition (EMT) found in migratory cells.
...
PMID:Expression profiling of stationary and migratory intestinal epithelial cells after in vitro wounding: restitution is accompanied by cell differentiation. 1959 Feb